IP Library › Granted Patent US 8,686,008
Granted Patent B2
US 8,686,008 · App. 12/785,217 · Granted Apr 1, 2014

Highly selective sigma receptor ligands

Inventors: Christopher R. McCurdy (Oxford, MS); Christophe Mesangeau (Oxford, MS); Rae Reiko Matsumoto (Morgantown, WV); Jacques Henri Poupaert (Brussels, BE); Bonnie Ann Avery (Oxford, MS); Ahmed Hassan Amin Abdelazeem (Oxford, MS)
Assignees: The University of Mississippi; L'Universite Catholique de Louvain
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,686,008
App. No.
12/785,217
Granted
Apr 1, 2014
Kind
B2
Abstract

Compounds having the general formula II, III, or IV wherein R 1 can be a radical of an optionally substituted C-4 to C-7 N-containing heterocycle or a radical of an optionally substituted cyclic or acyclic tertiary amine or isoindoline-1,3-dione: R 2,3,4,5,6 can each independently be any one or combinations of the following moieties, cyano, nitro, acyl, alkyl, amido, azido, isothiocyanate, isocyanate, optionally substituted anilino, halogens, ethers, sulfonamides, thioacyl, nitro, aromatic, heterocyclic, olefinic, acetylene, deuterium, or tritium; Y can be either CH, CH 2 , O, S, OCH 2 , N—R, N—Ar, C—R, C—Ar; Z can be either H, O, S, S—R or NR. R groups can be either H, aryls, alkyls, or cycloalkyls; “n” can be 1 to 5 carbons in length and stereoisomers, functional analogs, and pharmaceutically acceptable salts thereof and wherein the moiety bridging R 1 and N can be a substituted alkylene, optionally substituted alkenylene or optionally substituted alkynylene and where the alkylene group can include an inserted C 3 -C 5 cycloalkyl group, aromatic, and hetercocyclic group; wherein X′ is halogen, or C 1 -C 4 haloalyl; wherein the R x is a C 1 -C 5 straight chain or branched chain alkyl or a C 1 -C 4 straight chain or branched chain haloalkyl.

Claims (2)

1. A compound having the formula XIV

2. A pharmaceutical composition comprising the compound according to claim 1 and an acceptable carrier or excipient.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2010
From: MCCURDY, CHRISTOPHER R.; MESANGEAU, CHRISTOPHE; MATSUMOTO, RAE REIKO; POUPAERT, JACQUES HENRI; AVERY, BONNIE ANN; ABDELAZEEM, AHMED HASSAN AMIN
To: THE UNIVERSITY OF MISSISSIPPI; L'UNIVERSITE CATHOLIQUE DE LOUVAIN
Reel/Frame 025350/0765 →
Continuity (3)
Continuation In Part 12673486
Provisional Application 60956249 · Aug 16, 2007
Related Publication 20100329978A1 · Dec 30, 2010